The Technology Co.,Ltd.

Equities

A043090

KR7043090000

Industrial Machinery & Equipment

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
460 ^KRW	-0.43%		-2.54%	-28.12%

03-22	PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd.	CI
03-21	PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd.	CI

Diorpharm Co., Ltd. acquired 9.9% stake in PharmswellBio Co., Ltd. from IBDT Co., Ltd. for KRW 6.8 billion.

December 30, 2015 at 11:00 pm

Diorpharm Co., Ltd. acquired 9.9% stake in PharmswellBio Co., Ltd. (KOSDAQ:A043090) from IBDT Co., Ltd. for KRW 6.8 billion on December 24, 2015. Diorpharm offered KRW 3600 per PharmswellBio's share. In a related transaction, Diorpharm Co., Ltd. acquired 11.4% stake in PharmswellBio Co., Ltd. (KOSDAQ:A043090) from Service-In Co., Ltd for KRW 9.3 billion.

Diorpharm Co., Ltd. completed the acquisition of 9.9% stake in PharmswellBio Co., Ltd. (KOSDAQ:A043090) from IBDT Co., Ltd. on December 24, 2015.

Latest news about The Technology Co.,Ltd.

PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd.	03-21	CI
PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd.	03-20	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 24.999999475 billion in funding	23-08-17	CI
Kattus Co., Ltd. announced that it has received KRW 5.999 billion in funding from Exergy21 Co., Ltd.	23-05-02	CI
Kattus Co., Ltd. announced that it expects to receive KRW 5.999 billion in funding from Exergy21 Co., Ltd.	23-04-25	CI
Exergy21 Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 25 billion in funding	23-03-15	CI
Hanchang Biotech Co., Ltd. announced that it has received KRW 15 billion in funding from Exergy21.Inc	22-10-16	CI
HanChang Biotech to Raise $9.2 Million Through Stock Offering	22-08-04	MT
Hanchang Corporation entered into an agreement to acquire 73.98% for KRW 25 billion.	22-08-04	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 79.99999938 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.5 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Exergy21.Inc	22-08-03	CI
An undisclosed buyer agreed to acquire 8.6% stake in Hanchang Biotech Co., Ltd. from Hanchang Corporation for KRW 6.8 billion.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 27.49999938 billion in funding	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 11.99999925 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.49999938 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. acquired 5.61% stake in Hanju Chemical Company Ltd for KRW 2.7 billion.	21-12-26	CI
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 12.49999978 billion in funding from Hanchang Corporation, Jaanh Holdings Co., Ltd., CHOROKBAEM COMPANY Co., Ltd.	21-10-28	CI
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 8 billion in funding from Jiyuon Co., Ltd.	21-10-20	CI
Hanju Chemical & Holdings Co., Ltd. announced that it expects to receive KRW 8 billion in funding from Jiyuon Co., Ltd.	21-10-18	CI
Cube&Company Co., Ltd. announced that it expects to receive KRW 17.49999934 billion in funding from Jaanh Cosmetics, Inc.	21-06-15	CI
Cube&Company Co., Ltd. announced that it expects to receive KRW 12.49999978 billion in funding from CHOROKBAEM COMPANY Co., Ltd.	21-03-28	CI
PharmswellBio Co., Ltd. announced that it has received KRW 4.999997086 billion in funding from Cube Partners, C.S. Global Co., Ltd.	19-09-23	CI
PharmswellBio Co., Ltd.(KOSDAQ:A043090) dropped from S&P Global BMI Index	19-09-23	CI

Chart The Technology Co.,Ltd.

Duration

Period

More charts

Company Profile

Exergy21 Co Ltd, formerly Hanchang Biotech Co Ltd, is a Korea-based company mainly engaged in the development, manufacture and distribution of pharmaceutical raw materials. The Company operates its business through three segments. Distribution Business segment is mainly engaged in the food processing business, distribution business and others. PM business segment is mainly engaged in the provision of consulting services for real estate development projects, licensing, and contractor selection. Other segment is mainly engaged in the game publishing business, real estate business and others.

Sector

Industrial Machinery & Equipment

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Industrial Machinery & Equipment Wholesale

	1st Jan change	Capi.
THE TECHNOLOGY CO.,LTD.	-28.12%	23.85M
W.W. GRAINGER, INC.	+11.19%	44.53B
FASTENAL COMPANY	+1.87%	37.14B
APPLIED INDUSTRIAL TECHNOLOGIES, INC.	+11.76%	7.39B
DIPLOMA PLC	+14.24%	6.95B
MSC INDUSTRIAL DIRECT CO., INC.	-15.17%	4.78B
DISTRIBUTION SOLUTIONS GROUP, INC.	+5.77%	1.57B
DNOW INC.	+28.89%	1.51B
BUFAB AB	-0.21%	1.36B
MRC GLOBAL INC.	+20.71%	1.11B

Industrial Machinery & Equipment Wholesale